Over 20,000 business participants

Company Information

Company Hikma Pharmaceuticals Plc
www.hikma.com
Type:
Company
Country:
United Kingdom
Sector:
Pharmaceuticals & Biotechnology
Ownership:
Publicly Listed
Global Compact Status:
Active
Participant Since
12 December 2007
Next Communication on Progress (COP) due on:
31 July 2025

Financial Information

Twitter Feed from Hikma Pharmaceuticals Plc

Communication On Progress

Published On Title Level/Status
31-Jul-2024 2024 Communication on Progress Submitted
17-Nov-2023 2023 Communication on Progress Submitted
13-May-2022 Hikma Sustainability Report 2021 - Acting Responsibly Active
30-Jun-2021 2020 Sustainability Report and Communication on Progress Active
13-May-2021 Grace Letter Not applicable
03-Dec-2020 Reporting Cycle Adjustment Not applicable
04-Dec-2019 Hikma Pharmaceuticals Communication on Progress 2018 Active
05-Dec-2018 Hikma Communication on Progress 2017 Active
05-Dec-2017 Hikma Communication on Progress 2016 Active
07-Dec-2016 Communication on Progress 2015 Active
08-Dec-2015 Hikma Communication on Progress 2014 Active
09-Dec-2014 Hikma Communication on Progress 2013 Active
11-Dec-2013 Hikma Communication on Progress 2012 Active
13-Dec-2012 Hikma Communication on Progress 2011 Active
14-Dec-2011 Hikma Communication on Progress 2010 Active
14-Dec-2010 2009 Communication on Progress Not applicable
13-Dec-2009 Global Compact End of Year Communication on Progress (COP) 2008 Not applicable

Note: Responsibility for the content of participants' public communication related to the Ten Principles of the UN Global Compact and their implementation lies with participants themselves and not with the UN Global Compact.

Note on levels: Not applicable refers to the period when the Communication on Progress (CoP) did not require differentiation levels. With the new CoP , for the 2022 Early Adopter Programme, and for 2023, there will be no differentiation levels.